Condition: Lupus Nephritis (LN) · Sponsor: Regeneron Pharmaceuticals
This study is researching a particular group of experimental drugs administered for a short period in the treatment of participants with Lupus Nephritis (LN). The main aim of the current study is to see how safe and tolerable the study drugs are in a long-term follow-up. This is a main study, called an umbrella study, which includes several independent smaller sub-studies. Each of these smaller main sub-studies tests different drugs at the same time, all aimed at treating LN. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the drug less effective or could lead to side effects)
This description comes directly from the study's public registry record.
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Baylor College of Medicine | Houston, Texas, United States | Recruiting |
| Centre Hospitalier Universitaire (CHU) Bordeaux | Bordeaux, New Aquitaine, France | Recruiting |
| University Hospital Regensburg | Regensburg, Bavaria, Germany | Recruiting |
| University Medical Center of the Johannes Gutenberg-University Mainz | Mainz, Germany | Recruiting |
| Hallym University Sacred Heart Hospital | Anyang-si, Gyeonggi-do, South Korea | Recruiting |
| Seoul National University Hospital | Seoul, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
| Yonsei University College of Medicine, Severance Hospital | Seoul, South Korea | Recruiting |
| Hospital Universitario Virgen del Rocio | Seville, Andalusia, Spain | Recruiting |
| Clinica Universidad de Navarra | Pamplona, Navarre, Spain | Recruiting |
| Hospital Gregorio Maranon | Madrid, Spain | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06975787